Paul E. Morin - Concepedia

Author

Paul E. Morin

Bristol-Myers Squibb (United States)

Also Known As

Daniel M. Camac, Morin, Paul, P E Morin, P MORIN, P Morin, P. Morin, Paul E Morin, Paul E. Morin, Paul Morin

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)University of Toronto Johns Hopkins University Bristol-Myers Squibb (Sweden)

About

Paul E. Morin is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	773
2	Natural Sciences	13	13	470
3	Biochemistry	13	13	495
4	Health Sciences	2	2	95
5	Biomolecular Engineering	1	1	44

Paul E. Morin

Publications

2.8K

Citations

H-Index

Page 1

	Year	Citations
Use of MM-PBSA in Reproducing the Binding Free Energies to HIV-1 RT of TIBO Derivatives and Predicting the Binding Mode to HIV-1 RT of Efavirenz by Docking and MM-PBSA Junmei Wang, Paul E. Morin, Wei Wang, Journal of the American Chemical Society	2001	707
Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer Anna-Larissa N. Niemeijer, David Leung, Marc C. Huisman, Nature Communications	2018	460
Synthesis and Biologic Evaluation of a Novel <sup>18</sup>F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression David J. Donnelly, R. Adam Smith, Paul E. Morin, Journal of Nuclear Medicine	2017	190
Thermodynamic analysis of the structural stability of the tetrameric oligomerization domain of p53 tumor suppressor Craig R. Johnson, Paul E. Morin, C.H. Arrowsmith, Biochemistry	1995	120
Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase Robert G. Gentles, Min Ding, John A. Bender, Journal of Medicinal Chemistry	2014	98
Direct calorimetric analysis of the enzymic activity of yeast cytochrome c oxidase Paul E. Morin, Ernesto Freire Biochemistry	1991	94
Structures of Adnectin/Protein Complexes Reveal an Expanded Binding Footprint Vidhyashankar Ramamurthy, Stanley R. Krystek, Alexander A. Bush, Structure	2012	88
Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates Erin L. Cole, Joon‐Young Kim, David J. Donnelly, Bioorganic & Medicinal Chemistry Positron Emission TomographyNeuro-oncologyHealthy Non-human PrimatesPreclinical Pet EvaluationRadiopharmaceutical Therapy	2017	84
Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates Nigel J. Darby, Paul E. Morin, Gert Talbo, Journal of Molecular Biology Molecular PharmacologyBiochemistryMedicineNatural SciencesPeptide Therapeutic	1995	77
Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors Mimi L. Quan, Pancras C. Wong, Cailan Wang, Journal of Medicinal Chemistry Rabbit Thrombosis ModelsPharmacotherapyPharmaceutical ChemistryThrombosisMedicinal Chemistry	2014	76

Page 1